MiBB Regulatory

Independent EU MDR consultancy · Copenhagen, Denmark

Regulatory navigation for software-enabled medical devices.

Former Notified Body assessor based in Copenhagen. One senior consultant with direct accountability from classification through NB submission — for Nordic and EU manufacturers.

  • 6+ years reviewing MDR submissions at TÜV SÜD & DNV
  • Qualified PRRC under MDR Article 15
  • 100% focus on SaMD, AI/ML, and software-enabled devices
Mikkel Bruus-Borggaard, founder of MiBB Regulatory
Mikkel Bruus-Borggaard · Founder & Principal Consultant

6+years

Notified Body assessor

TÜV SÜD Denmark MHS & DNV

2NBs

Reviewed from inside

Know what auditors look for

7MDR codes

Active qualification scope

SaMD & software systems

1consultant

No agency hand-offs

You work directly with me

Is this a fit?

MiBB Regulatory is built for teams who need depth, not volume.

If several of these sound familiar, we should talk.

  • You are building SaMD, AI/ML-enabled, or software-heavy medical devices for the EU market.

  • You need a classification opinion you can defend — especially Rule 11 boundary cases.

  • You want technical documentation that survives Notified Body scrutiny, not template filler.

  • You need fractional PRRC coverage without hiring a full-time regulatory head.

  • You prefer one experienced consultant over a rotating agency team.

Quick check

Is your product regulated under EU MDR?

Answer a few questions for indicative qualification and classification guidance — aligned with MDCG 2019-11 and related guidance.

Transparent services

Defined deliverables at every stage of the MDR journey.

Gap Analysis

Regulatory readiness review across classification, documentation, and QMS maturity.

QMS Implementation

Lean ISO 13485-aligned quality system sized for your stage and team.

Technical Documentation & CER

Annex II/III technical files and clinical evaluation support for SaMD.

NB Preparation & Liaison

Submission readiness reviews and structured NB query response support.

PMS Setup + Fractional PRRC

Post-market surveillance design and Article 15 PRRC coverage.

Process

Typical MDR Journey for SaMD – How We Support Each Step

  1. Define

    Classification & strategy · Intended purpose · NB selection

  2. Build

    Documentation & QMS · IEC 62304 · Risk & cybersecurity

  3. Submit

    NB review prep · Query responses · Assessment meetings

  4. Sustain

    PMS & vigilance · Change control · Fractional PRRC

Documentation lifecycle

EU MDR Documentation Process Map

A structured overview of the documentation lifecycle for software medical devices (SaMD) under EU MDR — from design inputs through post-market surveillance, QMS certification, and the parallel cybersecurity risk management track.

1

Design inputs

  • Intended use & classification

    Rule 11 analysis, device scope

  • Applicable standards list

    IEC 62304, ISO 14971, 62366

  • System requirements

    Clinical, user & stakeholder needs

  • Design & development plan

    Milestones and review gates

  • Risk management plan

    ISO 14971, hazards and harms

  • Usability engineering plan

    IEC 62366, use specification

  • Clinical evaluation plan

    CEP, clinical strategy

2

Design outputs & V&V

  • Device description

    BoM, drawings, labelling

  • Software lifecycle docs

    IEC 62304, SDS, unit tests

  • Design FMEA

    Risk control verification

  • Verification plans & records

    Multi-level V&V protocols

  • Validation plan & report

    Clinical environment testing

  • Summative evaluation

    Use scenarios, hazard analysis

  • GSPR checklist

    Annex I, applied standards

3

Post-market

  • PMS plan

    Post-market surveillance

  • PMCF plan

    Post-market clinical follow-up

  • Clinical evaluation report

    CER, literature review

  • Plan and report

    PMS report / PSUR

  • Periodic safety update

    PMCF report

  • Follow-up results

4

QMS & NB review

  • QMS development

    ISO 13485, procedures, SOPs

  • NB stage 1 desk review

    Technical file completeness

  • NB stage 2 onsite audit

    QMS process audit

  • NB Q&A / negotiation

    Deficiency responses

  • ISO 13485 certificate

    QMS certification issued

  • CE mark certificate

    Market release authorised

  • STED

    Summary technical documentation

  • PRRC oversight

    Article 15, ongoing compliance

Cybersecurity track

Runs in parallel across all phases

  1. Intended use & assets

    Threats and vulnerabilities

  2. Cybersecurity risk analysis

    Threat/vulnerability estimation

  3. Risk control measures

    Implementation and verification

  4. Cybersecurity RM report

    Residual risk evaluation

  5. Post-production monitoring

    Vulnerability disclosure, patches

Cybersecurity risk feeds into ISO 14971 safety risk management — adverse impacts must be evaluated jointly.

Expertise

Credentials that matter to Notified Bodies — and to your team.

Six years on the assessor side of the table, backed by engineering and clinical experience. Based in Copenhagen, serving SaMD and AI device teams across Denmark, the Nordics, and the wider EU.

Assessor's perspective

Six years reviewing submissions at two Notified Bodies. I know which gaps stall assessments and which documentation patterns pass.

Engineering fluency

M.Sc. in biomedical engineering with hands-on firmware and DSP experience at GN Otometrics, GN ReSound, and B&O Medicom. I read your architecture diagrams.

Clinical grounding

Four years as a clinical engineer at Rigshospitalet — intraoperative monitoring during spinal surgery and hospital system rollouts. Real clinical risk context.

Background

  1. 2026 —

    Founder & Principal Consultant

    MiBB Regulatory

  2. 2022 — 2026

    Certified Technical Assessor

    TÜV SÜD Denmark MHS

  3. 2019 — 2022

    Certified Technical Assessor

    DNV Business Assurance

  4. 2015 — 2019

    Clinical Engineer

    Rigshospitalet

  5. 2013 — 2015

    Firmware Engineer

    GN Otometrics

  6. 2010 — 2013

    DSP / OS Engineer

    GN ReSound

  7. 2007 — 2010

    Software Engineer

    Bang & Olufsen Medicom

About

One consultant. Full accountability.

I founded MiBB Regulatory in Copenhagen after six years inside two Notified Bodies — because SaMD and AI device teams across Denmark and the Nordics deserve a consultant who has actually reviewed their documentation, not just written it.

Depth over breadth

You work with me directly. No juniors, no hand-offs, no account managers.

Pragmatic for start-ups

Lean QMS, focused documentation, and clear priorities — sized for where you are, not where a Big Four firm assumes you should be.

NB-ready deliverables

Every output is structured the way assessors expect. The goal is submission success, not document volume.

FAQ

Common questions about EU MDR, SaMD, and PRRC.

Straight answers to what manufacturers ask most — from classification through Notified Body submission.

How do I know if my software is a medical device under EU MDR?

EU MDR applies when software is intended for a medical purpose — defined by your intended purpose in labelling, instructions for use, and promotional material. General-purpose tools are out of scope; software that processes patient-specific data to support clinical decisions usually is. The first step is a written qualification and classification rationale before any technical documentation work begins.

Read our Rule 11 analysis

What is MDR Rule 11 and how does it affect SaMD classification?

Rule 11 of MDR Annex VIII classifies software that provides information used for diagnostic or therapeutic decisions. Most SaMD falls into Class IIa or higher depending on the severity of the clinical decision and the population affected. Rule 11 is not a bright-line test — classification depends on intended purpose, clinical context, and how directly the output drives decisions. AI-enabled software that generates patient-specific outputs is almost always in scope.

Read our Rule 11 analysis

Do I need a Person Responsible for Regulatory Compliance (PRRC)?

Under MDR Article 15, manufacturers must have a PRRC with the required qualifications and professional experience. For many start-ups and scale-ups, a full-time hire is not practical — fractional PRRC coverage lets you meet the legal requirement with a named, qualified person on your documentation without adding a permanent headcount.

Read our PRRC guide

What does the EU AI Act mean for AI-enabled medical devices?

From August 2026, high-risk AI system obligations apply to AI-enabled medical devices that fall under Annex III. If your device is MDR-regulated and uses AI, you likely face dual compliance under both frameworks. The good news: mature MDR documentation covers much of the foundation — but data governance, human oversight, and transparency requirements need explicit attention.

Read about the August 2026 deadline

How long does Notified Body submission typically take for SaMD?

Timelines vary by device class, NB workload, and documentation quality. Class IIa SaMD commonly takes 12–18 months from submission to certificate, but poor preparation — especially weak classification rationale, incomplete IEC 62304 evidence, or gaps in clinical evaluation — adds months of query cycles. Submission readiness review before you file is the highest-leverage step.

When should we engage an EU MDR consultant?

The earlier the better for classification and regulatory strategy — getting the intended purpose and class right before development locks in saves significant rework. For documentation and NB preparation, engage when you have a defined device and target market. For PRRC, engage before you need a named person on your declaration of conformity.

What deliverables can I expect from a scoped engagement?

Every engagement has defined outputs — not open-ended consulting hours. Typical deliverables include classification rationale memos, technical files aligned to MDR Annex II/III, QMS procedures, NB submission readiness reviews, query response support, and fractional PRRC coverage. Scope, timeline, and deliverables are agreed before work starts.

Do you work with companies outside Denmark?

Yes. MiBB Regulatory is based in Copenhagen and works with manufacturers across the Nordic region and the wider EU. All consultancy is delivered in English; Danish is also available. Remote collaboration is standard — most clients are outside Denmark.

Insights

Regulatory thinking for SaMD and AI teams.

Practical analysis with linked sources — plus weekly updates from EU regulators.

Regulatory updates

Filtered from EU health and EMA feeds. Refreshed weekly.

Last updated 13 Jul 2026

EU Medical Devices29 Jun 2026 · European Commission — Medical Devices

Medical Devices: Delegated acts on well-established technologies published

Medical Devices: Delegated acts on well-established technologies published

Read source ↗

EU Medical Devices18 Jun 2026 · European Commission — Medical Devices

New MDCG Position Paper: Management of SS(C)P in EUDAMED after mandatory use

New MDCG Position Paper: Management of SS(C)P in EUDAMED after mandatory use

Read source ↗

EU Medical Devices17 Jun 2026 · European Commission — Medical Devices

New guidance document on the “EU REP” symbol for authorised representatives

New guidance document on the “EU REP” symbol for authorised representatives

Read source ↗

EU Medical Devices17 Jun 2026 · European Commission — Medical Devices

New harmonised standards for the Regulations on medical devices

New harmonised standards for the Regulations on medical devices

Read source ↗

EU Medical Devices11 Jun 2026 · European Commission — Medical Devices

Update MIR 7.3.1. form – Updated XSD-XSL files for field 4.3.3.d. and Changelog file (SB 11252)

Update MIR 7.3.1. form – Updated XSD-XSL files for field 4.3.3.d. and Changelog file (SB 11252)

Read source ↗

EU Medical Devices18 May 2026 · European Commission — Medical Devices

New Implementing Regulation sets out uniform requirements for conformity assessment and notified bodies

New Implementing Regulation sets out uniform requirements for conformity assessment and notified bodies

Read source ↗

EU Medical Devices5 May 2026 · European Commission — Medical Devices

Implementing Regulation (EU) 2026/977 – uniform requirements for conformity assessment and notified bodies (Annex VII)

Implementing Regulation (EU) 2026/977 – uniform requirements for conformity assessment and notified bodies (Annex VII)

Read source ↗

EU Medical Devices22 Apr 2026 · European Commission — Medical Devices

Update – Documents on European Medical Device Nomenclature (EMDN)

Update – Documents on European Medical Device Nomenclature (EMDN)

Read source ↗

Contact

Start with a conversation

Tell me about your device and where you are in the regulatory journey. Based in Copenhagen — available to Nordic and EU teams remotely. I will be direct about whether I can help and what the first step looks like.

  • 30-minute introductory call
  • No sales pitch — straight technical discussion
  • Clear recommendation on next steps